In this issue:
- News from industries
- Web site update
- Journal Subscriptions
- Holiday Greetings
- Registrations for 2005-2006
|
 News from industries
A three CD rom disk set has been prepared under the supervision of M. Ferdeghini from the G.B. Rossi Hospital of Verona that offers a systematic revision of the different Imaging techniques in oncology. The first two CDs are educational and they provide an update on the method of utilization and on the limits of each available technique. The third one is an interactive CD and provides a sharing on behalf of the clinic of he research choices to use, accordingly with the other specialists involved in the diagnosis.
In order to request your free CD, just log on to Novartis web site at www.novartis.it.
|
Web site update
For those of you who still aren't aware of it, our web site has an Atlas section where we'd like to collect pictures of interesting clinical cases, as well as theses, presentations and lectures.
In order to do so, we need your collaboration so please feel free to submit anything you'd like.
Furthermore, we'd like to inform you that the site also has a Forum where any member can suggest topics and/or reply to questions.
Every new question generates an automatic e-mail that informs each member on the discussion in progress.
|
Journal subscriptions
 As you may or may not know, the Quarterly Journal of Nuclear Medicine (QJNM) accepted the offer that was presented granting that our President be named Associate Editor and dedicating a set number of pages to our Society's members. The irist assembly previously agreed on the necessity of an official journal and it was unanimously approved the offer presented by the QJNM. This journal has now an Impact Factor of 2.2, being amongst the 4 best rating journals in our field. In the December issue of the Journal you can find an editorial written by our President Dr. Christophe Van de Wiele on this important agreement.
In practical terms all irist members that whish to submit a paper to QJNM can send it directly to our section Editor that will take care of the reviewing process with high speed and efficiency. Please take advantage of this important achievement of our society. Send your papers to:
Dr. Christophe Van de Wiele
Associate Editor QJNM (IRIST section)
Nuclear Medicine Unit
University Hospital Ghent
De Pintelaan 185
B-9000 Ghent, Belgium
 Let us also remind you the offer of Cancer Biotherapy & Radiopharmaceuticals (CB&R) that, thanks to Prof. G. De Nardo, can be received by irist members at the special subscription fee of 30 Euro per year!
This journal very often publishes papers in the field of irist, with particular regard to monoclonal antibodies and peptides for diagnosis and therapy and dosimetry studies. In addition there are a number of clinical papers and meeting reports that are very useful for being updated in this field.
|
Holiday Greetings
 We'd like to take this opportunity to wish all our members and their families best wishes for the upcoming holiday season!! May the new year bring prosperity and serenity to you all.
|
IRIST Registrations for 2005-2006
We'd like to remind all those who still haven't done so that subscriptions for the year 2005-2006 have already begun.
How to subscribe?
It's really simple: just visit our web-site and select Become a Member and follow the simple instructions.
It will only take you a few minutes and you'll be given your personal username and password immediately.
This is your last chance to get QJNM and CB&R subscription for 2005 at reduced cost!
|
Contact Us
We are setting the new IRIST secretariat to provide help and assistance to all our members.
All IRIST members are welcomed to e-mail us every time they are in need of any type of information. Our secretaries Cristina and Misha will be at their service and will answer their request as quickly as possible.
Questions, comments, and suggestions should be directed to:
 IRIST
Via G. Baglivi 12
00161 Roma, Italy
tel. +39-06-4402565
fax. +39-06-4402565
email:
|
Unsubscribe
Please us with "unsubscribe" in the subject header and we'll promptly remove you from our mailing list. Thank you. |
